NEW YORK , June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
Month: June 2023
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sea Limited (“Sea” or the “Company”) (NYSE: SE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation…
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
NEW YORK, June 23, 2023 /PRNewswire/ — The latest report on the voice speech recognition software market, from 2022 to 2027 estimates to register an incremental growth of USD 14,859.93 million, at a CAGR of 13.72% during the forecast period. Download a Sample Report! Voice Speech…
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Franchise Group, Inc. (“Franchise Group” or the “Company”) (NASDAQ: FRG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. (“Arcellx” or the “Company”) (NASDAQ: ACLX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, June 23, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. (“Mersana” or the “Company”) (NASDAQ: MRSN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980….
NEW ORLEANS, June 23, 2023 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against…